Reduction of colony-forming cell sensitivity to arabinosylcytosine by halothane anesthesia.
D000769:Anesthesia, Inhalation; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D003561:Cytarabine / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006221:Halothane; D008223:Lymphoma / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009609:Nitrous Oxide; D013160:Splenic Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use
D003561:Cytarabine; D014747:Vinblastine; D009609:Nitrous Oxide; D006221:Halothane